Efficacy and tolerability of renzapride in irritable bowel syndrome: a meta-analysis of randomized, controlled clinical trials including 2528 patients

INTRODUCTION: By targeting different subtypes of 5-hydroxytryptamine (5HT) receptors in the gastrointestinal (GI) tract, several drugs have been introduced for the management of irritable bowel syndrome (IBS). Renzapride is a full agonist for 5HT4 receptor and an antagonist to 5HT2b and 5HT3 recepto...

Descripción completa

Detalles Bibliográficos
Autores principales: Mozaffari, Shilan, Nikfar, Shekoufeh, Abdollahi, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2014
Materias:
Systematic review/Meta-analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3953973/
https://www.ncbi.nlm.nih.gov/pubmed/24701208
http://dx.doi.org/10.5114/aoms.2014.40729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3953973/
https://www.ncbi.nlm.nih.gov/pubmed/24701208
http://dx.doi.org/10.5114/aoms.2014.40729

Ejemplares similares